Features
Latest World Pharmaceuticals Feature
The industry faces a number of barriers in terms of pricing, as well...
> read more
The fourth wave A lot has been written on big data and industry 4.0, and how they are rapidly transforming a number of different industries. However, not so much attention has been paid to how...
Child’s play Meeting both regulatory and patient needs in packaging of pharmaceuticals can be highly challenging for manufacturers, especially in the case of child-resistant packaging. There are...
Weather the storm Global pharmaceutical supply chains are weak; there are many manufacturing issues and a lack of incentives to continue to produce less profitable but necessary medicines. Allie...
A breath of fresh air Transporting pharmaceutical products by air requires complex logistical processes, specific equipment, storage facilities and harmonised handling procedures to maintain...
Small actions with deep impacts Supercritical fluid technologies have grown in popularity in recent years, due to their low impact on the environment as well as their ability to streamline development and save...
Get connected The internet of things (IoT) offers huge potential to improve efficiencies across the supply chain. These technologies provide real-time data about products and conditions,...
Power to the people Over half of the states in the US now have legalised cannabis in some form and, since November 2018, it is available on prescription for certain conditions within the UK NHS. However,...
A link too few? It has been implemented in the supply chains and procurement processes of several industries from diamonds to produce. Now, with new electronic serialisation measures, analysts say...
Stick it out More than 1,800 claims for needle-stick injuries were made in the UK in a five-year period. However, most were likely avoidable if needle-stick prevention systems had been put in...
The compliance conundrum For smaller pharma and their suppliers, meeting legal requirements has long been a signifi cant challenge. GS1’s Geraldine Lissalde-Bonnet and Centrient Pharmaceuticals’ Robert-Jan...
Targeted delivery For 100 years, humankind has struggled to effectively administer biologic drugs through pills, as large molecules are vulnerable to the ravages of the digestive system. With solutions...
Keep it cool In a world where supply chains can span multiple national borders, and the regulatory environment is becoming more demanding, good collaboration between partners is essential. Kim...
Compare and contrast Choosing comparators is often an onerous process that involves navigating a lot of different models. A key decision is choosing between global and local sourcing. David...
Strong ties Social media is a powerful tool for patient recruitment, providing a valuable addition to more traditional methods. It can be harnessed to build strong relationships between...
Cool runnings With the stakes being so high for cold chain, finding new ways to maximise efficiencies and prevent revenue losses is key. Digitisation is a cost-effective option with huge potential,...
New direction The growth of direct-to-patient (DtP) clinical trial strategies is expected to continue for the foreseeable future. Adopting a DtP approach has the potential to improve...
A sea change The last 25 years have seen a dramatic evolution in clinical trials and processes. The delivery of investigational medicinal products to clinical sites and patients is...
Ride the tidal wave of data The variety and quantity of data available for clinical trials is greater than ever before. While this promises huge benefits in terms of monitoring subjects and measuring results,...
Perfect harmony The way clinical trials are conducted in the EU will experience a significant shift when Regulation (EU) no. 536/2014 (termed Clinical Trial Regulation) is implemented in 2019 and...
View all features A-Z
